Why every startup should file a patent early

Introduction

There are two conversations every founder eventually has with an investor. One's about the product. The other's about defensibility. "What stops a larger competitor from copying this once you prove the market?" is the question behind both, and for anything with a technical edge, the answer lives or dies on IP.

Most founders know this. They still postpone filing. The reasons are familiar: patents feel expensive, the process feels slow, and the return feels abstract. Those concerns were valid ten years ago. They're mostly wrong today, and the cost of acting on them has become sharper every year.

This article isn't a pitch to patent everything. Some ideas shouldn't be patented; some are better protected by trade secret or speed. But for the majority of technical startups, filing early is the single highest-leverage legal action available, and the window to do it correctly is narrower than most founders realise.

‍

First-to-file is not a detail

Europe, the UK, China, Japan and almost every other major jurisdiction run on a first-to-file system. Whoever walks into the patent office first wins, even if someone else invented the same thing six months earlier in their garage. The United States moved to a first-to-file system in 2013.

This is the point most founders underestimate. Two startups independently arriving at the same idea is not rare; it is the default. If your competitor files first, they get the priority date. You do not get a second-place prize. You get a cease-and-desist letter.

The priority date is the single most valuable asset a patent gives you. Once it is locked in, nobody else can patent the same invention, anywhere in the world, for twelve months. You use those twelve months to validate the market, raise money, and decide whether to go global.

‍

How a pending application changes the investor conversation

Investors do not read your patent. They check whether you have one. A pending application, even at the earliest stage, answers the defensibility question in a way no pitch deck can. It signals three things at once:

• You treat your own invention as valuable enough to protect.
• A qualified attorney thought the invention was novel enough to draft claims around.
• Your priority date is locked, so a later-moving competitor cannot patent around you.

The valuation effect is measurable. Multiple studies over the past decade have tracked European deep-tech startups and found that companies with filed IP raise at higher valuations than identical companies without. The effect is largest at seed and Series A, exactly when founders are most cash-constrained and most tempted to defer filing.

‍

Grants increasingly require IP, and reward it

Innovate UK, Horizon Europe, the EIC Accelerator and most national R&D funding schemes now ask about IP status in the application. Some reject outright if there is no filing strategy. Others add scoring weight for applicants with pending or granted patents. A €1,999 filing that unlocks a €250,000 grant has paid for itself roughly 125 times over.

Grant reviewers are not looking for granted patents. They know that timeline does not match an early-stage startup. They are looking for evidence that you have taken IP seriously enough to file. A pending application meets that bar.

‍

The one reason to delay, and the trap inside it

There is a legitimate reason to delay filing: the invention is not yet ready. Patents must disclose enough detail that a skilled person could reproduce the invention. If the core mechanism is still changing every week, filing too early risks claiming something that turns out not to be what you build.

The trap is that this becomes the universal excuse. "Not yet ready" is true for six months, and then it is a story founders tell themselves for three years while competitors move. A simple test: if you have shown the invention to any third party, an investor, a pilot customer, an accelerator, it is ready enough to file. Public disclosure before filing is the single most common way founders destroy their own patentability, and it is always avoidable.

‍

What filing actually looks like in 2026

The traditional process, three months, multiple meetings, open-ended invoices, is no longer the only option. Online platforms with attorney validation compress the timeline to days and the cost to a fixed fee. The trade-off is not quality; the attorney still drafts the claims and signs off on the filing. The trade-off is convenience: less of your time, less of the attorney's time, and therefore less of your money.

For most early-stage startups, that is the right trade-off. You do not need boutique-firm treatment for your first filing. You need a clean application, a locked priority date, and the twelve-month window to decide what comes next.

Every month you delay filing is a month a competitor can legally file the same idea. It's a month your fundraise conversation includes an unanswered defensibility question. It's a month your grant application loses points.

Filing isn't the last step of validation. It's one of the first.

‍

Conclusion

Every month you delay filing is a month a competitor can legally file the same idea. It's a month your fundraise conversation includes an unanswered defensibility question. It's a month your grant application loses points.

Filing isn't the last step of validation. It's one of the first.

File before the window closes.

‍

Frequently asked questions

‍

Why should a startup file a patent early rather than waiting?

Because patents go to the first to file, not the first to invent. Every day you delay is a day a competitor can file the same invention and take the priority date. Early filing also protects against disclosure risk: any public description of how your invention works, before filing, can permanently destroy your ability to patent it in Europe. The cost of filing early is fixed and predictable. The cost of filing late can be permanent loss of rights.

‍

How does a patent affect a startup's valuation at fundraising?

Research on European deep-tech startups consistently shows that companies with filed IP raise at higher valuations than comparable companies without. Investors price defensibility into their models. A pending patent application signals that the technology is novel, that a qualified attorney assessed it as worth protecting, and that the priority date is locked against later-moving competitors. The effect is most pronounced at seed and Series A.

‍

Do you need a granted patent to benefit from IP protection?

No. A pending application provides most of the commercial benefit of a granted patent from the moment of filing. It gives you a priority date that blocks competitors, a legally meaningful status you can cite to investors and partners, and retrospective enforcement rights once the patent is granted. For most startups, the priority date is more commercially important than the grant date, which typically arrives three to five years later.

‍

Does filing a patent help with European grant applications such as Horizon Europe or EIC?

Yes. Innovate UK, Horizon Europe, the EIC Accelerator, and most national R&D funding schemes ask about IP status and reward applicants who have active filings. Some programmes require a filing strategy as a condition of eligibility. Grant reviewers do not expect a granted patent from an early-stage startup; they expect evidence that IP has been taken seriously. A pending application meets that bar and can be the difference between scoring well and being filtered out.